RNS Number : 2734Z
Latham(James) PLC
02 April 2026
James Latham plc
("James Latham" or "the Company")
Director/PDMR Shareholding
The Board of James Latham announces that, on 1 April 2026, the Trustees of the Company's Deferred Bonus Scheme 2012 issued 3,019 ordinary shares of 25p each in the Company to Andrew Wright, Managing Director, following the exercise of the options under the Company's Deferred Bonus Scheme 2012 issued on 1 April 2023. Mr Wright's resultant shareholding is 34,765 shares or 0.17% of the issued share capital of the Company.
For further information please visit www.lathamtimber.co.uk, or contact:
James Latham plc
Tel: 01442 849 100
Nick Latham, Chairman
David Dunmow, Finance Director
SP Angel Corporate Finance LLP
Matthew Johnson / Caroline Rowe (Corporate Finance)
Tel: 0203 470 0470
Abigail Wayne / Rob Rees (Corporate Broking)
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
1.
Andrew Wright
2
Reason for the notification
a)
Position/status
1.
Managing Director
b)
Initial notification /Amendment
InitialNotification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
James Latham plc
b)
LEI
2138008M4LVEDHBPBU41
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of 25p each
Identification code
GB00B04NP100
b)
Nature of the transaction
Exercise of options over Ordinary Shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
1.
Nil
1.
3,019
d)
Aggregated information
- Aggregated volume
As above
- Price
e)
Date of the transaction
1 April 2026
f)
Place of the transaction
Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHSSDSUEEMSEEL
